Matches in Ubergraph for { ?s <http://purl.obolibrary.org/obo/NCIT_P302> ?o ?g. }
- NCIT_C1647 NCIT_P302 "Breast cancer overexpressing HER2 protein; Pancreatic cancer overexpressing p185HER2" @default.
- NCIT_C1654 NCIT_P302 "Vitamin supplement" @default.
- NCIT_C166389 NCIT_P302 "the first-line treatment of adult patients with metastatic non-squamous non-small cell lung cancer (NSCLC) with no EGFR or ALK genomic tumor aberrations." @default.
- NCIT_C166575 NCIT_P302 "Use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults. Treatment of schizophrenia in adults and pediatric patients ages 13 years and older." @default.
- NCIT_C166954 NCIT_P302 "for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) whose tumors are positive for an EZH2 mutation" @default.
- NCIT_C1670 NCIT_P302 "Osteoporosis, treatment and prevention" @default.
- NCIT_C1681 NCIT_P302 "Chronic Lymphocytic Leukemia (CLL)" @default.
- NCIT_C1685 NCIT_P302 "metastatic non-small cell lung cancer" @default.
- NCIT_C1687 NCIT_P302 "Philadelphia chromosome-positive chronic myelogenous leukemia and acute lymphocytic leukemia, gastrointestinal stromal tumor, hypereosinophillic syndrome, dermatofibrosarcoma protuberans, mutated-PDGFR myelodysplastic/myeloproliferative diseases." @default.
- NCIT_C1691 NCIT_P302 "unresectable or metastatic liposarcoma or leiomyosarcoma" @default.
- NCIT_C1699 NCIT_P302 "Hypercalcemia of malignancy; Multiple myeloma and metastatic bone lesions from solid tumors; Paget's disease" @default.
- NCIT_C169981 NCIT_P302 "to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)." @default.
- NCIT_C1702 NCIT_P302 "Diffuse Large B-cell, CD20-positive, Non-Hodgkins Lymphoma (NHL)" @default.
- NCIT_C170224 NCIT_P302 "for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease." @default.
- NCIT_C1704 NCIT_P302 "T-cell Acute Lymphoblastic Leukemia; T-cell Lymphoblastic Lymphoma" @default.
- NCIT_C170439 NCIT_P302 "mantle cell lymphoma" @default.
- NCIT_C1707 NCIT_P302 "Aspergillosis, invasive; Esophageal candidiasis; Fungal infections, non-aspergillosis" @default.
- NCIT_C171041 NCIT_P302 "first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)." @default.
- NCIT_C171042 NCIT_P302 "first-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC)." @default.
- NCIT_C171375 NCIT_P302 "adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting." @default.
- NCIT_C171722 NCIT_P302 "patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP" @default.
- NCIT_C171761 NCIT_P302 "adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations." @default.
- NCIT_C171898 NCIT_P302 "postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer" @default.
- NCIT_C172134 NCIT_P302 "bevacizumab for first-line maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to first-line platinum-based chemotherapy and whose cancer is associated with homologous recombination deficiency positive status defined by either a deleterious or suspected deleterious BRCA mutation, and/or genomic instability." @default.
- NCIT_C1723 NCIT_P302 "Advanced colorectal cancer; Head and neck cancer" @default.
- NCIT_C1728 NCIT_P302 "Acute pain; Familial adenomatous polyposis; Primary dysmenorrhea; Osteoarthritis; Rheumatoid arthritis" @default.
- NCIT_C173055 NCIT_P302 "for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older." @default.
- NCIT_C173339 NCIT_P302 "HER2 overexpressing breast cancer" @default.
- NCIT_C1736 NCIT_P302 "Diseases involving fibrosis and nonsuppurative inflammation" @default.
- NCIT_C173743 NCIT_P302 "emergency use authorization (EUA) : for emergency use as post-exposure prophylaxis (prevention) for COVID-19 in adults and pediatric individuals (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death." @default.
- NCIT_C1739 NCIT_P302 "Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Neuroblastoma" @default.
- NCIT_C174704 NCIT_P302 "management of acute pain" @default.
- NCIT_C175056 NCIT_P302 "for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy." @default.
- NCIT_C175088 NCIT_P302 "unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement" @default.
- NCIT_C175834 NCIT_P302 "adult patients with ovarian cancer as an adjunct for interoperative identification of malignant lesions." @default.
- NCIT_C1762 NCIT_P302 "Breast cancer prevention" @default.
- NCIT_C177059 NCIT_P302 "the treatment of mild-to-moderate COVID-19 in adults and pediatric patients-emergency use authorization (EUA)." @default.
- NCIT_C1777 NCIT_P302 "Hematopoietic Stem Cell Mobilization" @default.
- NCIT_C1784 NCIT_P302 "Epithelial ovarian cancer" @default.
- NCIT_C1789 NCIT_P302 "Ankylosis spondylitis; Crohns disease; Plaque psoriasis; Rheumatoid arthritis; Sarcoidosis" @default.
- NCIT_C1794 NCIT_P302 "Breast cancer; Colorectal cancer, Stage III colon cancer" @default.
- NCIT_C1796 NCIT_P302 "Cutaneous T-cell Lymphoma" @default.
- NCIT_C1803 NCIT_P302 "Heart disease prevention; hyperlipidemia; menopausal symptoms" @default.
- NCIT_C1806 NCIT_P302 "Acute Myeloid Leukemia." @default.
- NCIT_C1812 NCIT_P302 "Non-Hodgkin's Lymphoma" @default.
- NCIT_C1818 NCIT_P302 "Gallstone disolution; Primary biliary cirrhosis" @default.
- NCIT_C181916 NCIT_P302 "adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy." @default.
- NCIT_C1820 NCIT_P302 "Gastric Carcinoma" @default.
- NCIT_C1820 NCIT_P302 "Pancreatic Adenocarcinoma" @default.
- NCIT_C1823 NCIT_P302 "Multiple sclerosis" @default.
- NCIT_C18296 NCIT_P302 "Enzyme replacement; Pancreatic function, presumptive test" @default.
- NCIT_C1832 NCIT_P302 "Pain; dysmenorrhea; osteoarthritis; rheumatoid arthritis" @default.
- NCIT_C1837 NCIT_P302 "Depression" @default.
- NCIT_C1841 NCIT_P302 "Prostate Cancer" @default.
- NCIT_C1844 NCIT_P302 "Advanced renal cell carcinoma" @default.
- NCIT_C1844 NCIT_P302 "Renal Cell Carcinoma" @default.
- NCIT_C1845 NCIT_P302 "chronic hepatitis C; renal cell carcinoma" @default.
- NCIT_C1848 NCIT_P302 "African trypanosomiasis; onchocerciasis" @default.
- NCIT_C184955 NCIT_P302 "hepatocellular carcinoma (HCC)" @default.
- NCIT_C1851 NCIT_P302 "Multiple Myeloma; Advanced Thyroid Cancer" @default.
- NCIT_C1854 NCIT_P302 "Chemotherapy-induced neutropenia" @default.
- NCIT_C1855 NCIT_P302 "Non-Small Cell Lung Carcinoma" @default.
- NCIT_C1857 NCIT_P302 "Advanced Stage Colorectal Cancer" @default.
- NCIT_C185891 NCIT_P302 "Myelofibrosis With Severe Thrombocytopenia" @default.
- NCIT_C186395 NCIT_P302 "in combination with other antiretroviral(s), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection" @default.
- NCIT_C186440 NCIT_P302 "for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma." @default.
- NCIT_C186575 NCIT_P302 "Hypogonadism -- Male" @default.
- NCIT_C1869 NCIT_P302 "Osteoarthritis; rheumatoid arthritis; dysmenorrhea" @default.
- NCIT_C1872 NCIT_P302 "acute myeloid leukemia (AML) who are FLT3 mutation-positive (FLT3+)" @default.
- NCIT_C1878 NCIT_P302 "Chemotherapy-induced anemia; chronic renal failure/insufficiency" @default.
- NCIT_C1887 NCIT_P302 "Systemic lupus erythematosus" @default.
- NCIT_C190727 NCIT_P302 "Prostate cancer" @default.
- NCIT_C191876 NCIT_P302 "adult patients with deleterious or suspected deleterious BRCA-mutated castration-resistant prostate cancer (mCRPC)." @default.
- NCIT_C192 NCIT_P302 "Ifosfamide-induced hemorrhagic cystitis, prophylaxis" @default.
- NCIT_C195 NCIT_P302 "Acute lymphocytic leukemia; Acute myelogenous leukemia; Crohns disease; Hodgkins lymphoma in children; Lymphoblastic lymphoma; Ulcerative colitis" @default.
- NCIT_C1952 NCIT_P302 "Chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia; hairy cell leukemia; chronic hepatitis C; AIDs-related Kaposis sarcoma; bladder; ovarian; cervical cancer; non-Hodgkins lymphoma; renal cell carcinoma; melanoma." @default.
- NCIT_C200 NCIT_P302 "Acetaminophen Overdose" @default.
- NCIT_C2015 NCIT_P302 "Prostate Cancer" @default.
- NCIT_C2039 NCIT_P302 "Metastatic Colorectal Cancer, Non-small Cell Lung Cancer, glioblastoma; Metastatic Renal Cell Carcinoma; persistent, recurrent or metastatic cervical cancer; epithelial ovarian, fallopian tube, or primary peritoneal cancer" @default.
- NCIT_C2068 NCIT_P302 "Malignant melanoma" @default.
- NCIT_C211 NCIT_P302 "Inflammation" @default.
- NCIT_C2194 NCIT_P302 "Advanced renal cell carcinoma; Metastatic Colorectal Cancer" @default.
- NCIT_C2194 NCIT_P302 "Major Depressive Disorder" @default.
- NCIT_C2213 NCIT_P302 "Acute Nonlymphocytic Leukemia; Acute Lymphocytic Leukemia; Advanced HIV-associated Karposi Sarcoma." @default.
- NCIT_C2220 NCIT_P302 "Chronic Hepatitis C" @default.
- NCIT_C225 NCIT_P302 "See specific agents." @default.
- NCIT_C226 NCIT_P302 "Hirsutism, facial; Trypanosoma brucei gambiense (sleeping sickness) infection" @default.
- NCIT_C2265 NCIT_P302 "Adrenal insufficiency, replacement; Systemic lupus erythematosus, treatment and steroid treatment reduction" @default.
- NCIT_C228 NCIT_P302 "Allergy, diagnosis" @default.
- NCIT_C2295 NCIT_P302 "Advanced androgen-dependent prostate cancer, palliative; Breast cancer, palliative; Estrogen replacement; Menopausal symptoms; Postmenopausal osteoporosis" @default.
- NCIT_C2327 NCIT_P302 "Pellegra, treatment and prophylaxis; Various dermatologic conditions" @default.
- NCIT_C2351 NCIT_P302 "Various diseases or injuries associated with hypoxia" @default.
- NCIT_C236 NCIT_P302 "Ventricular Fibrillation and Ventricular Tachycardia" @default.
- NCIT_C2379 NCIT_P302 "Mitochondrial disease; emergency treatment following a fluorouracil or capecitabine administration" @default.
- NCIT_C2381 NCIT_P302 "juvenile arthritis; psoriatic arthritis; rheumatoid arthritis." @default.
- NCIT_C2388 NCIT_P302 "Lymphomatous meningitis" @default.
- NCIT_C2403 NCIT_P302 "Cervical cancer" @default.
- NCIT_C2404 NCIT_P302 "Chemotherapy-induced acute hyperuricemia, treatment and prophylaxis" @default.
- NCIT_C2413 NCIT_P302 "neoadjuvant therapy for patients with squamous cell carcinoma of the head and neck" @default.
- NCIT_C2423 NCIT_P302 "Primary ovarian cancer" @default.